Dimethyl Fumarate‐Associated Acute Hepatocellular Injury Assessed for Causality Using the Updated RUCAM: A Biopsy‐Supported Case Report
Ophir Lavon, Maram Salameh · 2026
Read Dimethyl Fumarate‐Associated Acute Hepatocellular Injury Assessed for Causality Using the Updated RUCAM: A Biopsy‐Supported Case Report by Ophir Lavon, Maram Salameh (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13559025.txt.
Description
Ophir Lavon and Maram Salameh offer a 2026 case report of acute liver injury tied to dimethyl fumarate, a drug for multiple sclerosis. In a 26-year-old woman, liver enzymes rose soon after she started the drug. A liver biopsy supported drug-induced injury. A standard causality score, the updated RUCAM, gave 6, which marks probable cause, and stopping the drug fit that reading. A negative antibody test lowered the chance of autoimmune hepatitis. Hepatitis E was not tested, which left one rival cause open and kept full certainty out of reach.
Catalog record
| CREATOR | Ophir Lavon, Maram Salameh |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 15 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |